Immunome (IMNM) Upgraded to Buy: Here's What You Should Know

• click to rate

  Posted by Two Blokes Jun 16 - Filed in Stock - 6 views
  
  Immunome (IMNM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.